Clinical Trial Update: Study of the Safety and Efficacy of Intravenous Alpha-1 Antitrypsin in Type 1 Diabetes Mellitus [Phase 1, Phase 2]

View source ↗

Summary

The study reports completion of Phase 1 and Phase 2 clinical trials evaluating intravenous alpha-1 antitrypsin for safety and efficacy in individuals with Type …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Glassia (alpha-1 proteinase inhibitor)

Snippet

Sponsor: Kamada, Ltd. | Conditions: Type 1 Diabetes Mellitus | Phase 1, Phase 2 | Status: COMPLETED